Fecal transplant registry for donors and recipients
Part of Digestive system clinical trials.
This is a registry that collects information from adults who either receive fecal microbiota transplant (FMT) or plan to receive it, and from people who have donated—or plan to donate—stool for FMT. It helps researchers understand who participates in these gut-microbiome treatments in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be able to give written informed consent
- You have received FMT or other gut-microbiome products, or you plan to
- You are either an FMT recipient or someone who has donated/plans to donate stool for FMT
- You may still be included even if screening for FMT doesn’t work out
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This study is a national “registry” that collects information from people who get fecal microbiota transplant (a stool-based treatment) and from people who donate stool. It helps researchers understand who receives these treatments and how they do over time.
This study creates a registry for people who receive fecal microbiota transplants (FMT) to track long-term safety and outcomes. It may help researchers understand how this treatment works over time.
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.